JiangSu WuZhong Pharmaceutical Development Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,034.598 million compared to CNY 1,119.283 million a year ago. Operating income was CNY 82.268 million compared to operating loss of CNY 21.476 million a year ago. Net income was CNY 69.603 million compared to net loss of CNY 18.609 million a year ago. Basic earnings per share from continuing operations was CNY 0.098 compared to basic loss per share from continuing operations of CNY 0.026 a year ago.